Oligodendrocyte death and demyelination accompany many CNS insults, and these features are particularly prominent in spinal cord trauma. White matter injury, including demyelination, are the major cause of disability after spinal cord injury (SCI). Despite the clinical importance of this problem, the cellular and molecular mechanisms contributing to oligodendrocyte death are unclear. Since oligodendrocytes express functional AMPA-type glutamate receptors and elevated glutamate levels accompany SCI, we plan to explore the possibility that spinal cord oligodendrocytes are vulnerable to AMPA/kainate (KA) receptor-mediated excitotoxic death and examine whether this mechanism may contribute to the loss of oligodendrocytes and demyelination following SCI. Our preliminary data suggest oligodendrocytes, in vitro and in vivo, express functional AMPA/KA receptors, and are killed by AMPA/KA receptor overactivation. An initial characterization of the development, physiology and pathophysiology of AMPA/KA receptors will be completed in pure cultures of oligodendrocytes isolated from adult rodent spinal cord. Our preliminary data in vivo raise the specific possibility that a delayed and protracted excitotoxicity may contribute, in part, to the delayed oligodendrocyte death following SCI. If verified by these studies, this would be a novel and important concept in our understanding of the mechanisms of oligodendrocyte death, extending the excitotoxicity hypothesis to include non-neuronal cells and involvement in delayed mechanisms of SCI. The ultrastructural features and temporal pattern of oligodendrocyte death following SCI will be assessed using contusion and dorsal hemisection injury in adult rodents. Parallel studies using long term culture of intact brain and spinal cord will be carried out to investigate the mechanisms of oligodendrocyte death in the absence of factors complicating in vivo studies. We will further examine whether oligodendrocyte death and demyelination are reduced and the functional outcome improved by strategies designed to ameliorate AMPA/KA receptor excitotoxicity. The ultimate goal of this project is to enhance functional recovery after SCI, by understanding and limiting oligodendrocyte death and demyelination.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS037927-05
Application #
6529234
Study Section
Neurology B Subcommittee 2 (NEUB)
Program Officer
Chiu, Arlene Y
Project Start
1998-09-01
Project End
2003-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
5
Fiscal Year
2002
Total Cost
$74,696
Indirect Cost
Name
Washington University
Department
Neurology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Dilmanian, F Avraham; Qu, Yun; Feinendegen, Ludwig E et al. (2007) Tissue-sparing effect of x-ray microplanar beams particularly in the CNS: is a bystander effect involved? Exp Hematol 35:69-77
McDonald, John W; Becker, Daniel (2003) Spinal cord injury: promising interventions and realistic goals. Am J Phys Med Rehabil 82:S38-49
Leuchtmann, Elizabeth A; Ratner, Andrea E; Vijitruth, Rattanavijit et al. (2003) AMPA receptors are the major mediators of excitotoxic death in mature oligodendrocytes. Neurobiol Dis 14:336-48
Qu, Y; Vadivelu, S; Choi, L et al. (2003) Neurons derived from embryonic stem (ES) cells resemble normal neurons in their vulnerability to excitotoxic death. Exp Neurol 184:326-36
Becker, Daniel; Sadowsky, Cristina L; McDonald, John W (2003) Restoring function after spinal cord injury. Neurologist 9:1-15
Dong, Hongxin; Fazzaro, Alicia; Xiang, Chuanxi et al. (2003) Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration. J Neurosci 23:8682-91
McDonald, John W; Sadowsky, Cristina (2002) Spinal-cord injury. Lancet 359:417-25
McDonald, John W; Howard, Michael J (2002) Repairing the damaged spinal cord: a summary of our early success with embryonic stem cell transplantation and remyelination. Prog Brain Res 137:299-309
Grill, W M; McDonald, J W; Peckham, P H et al. (2001) At the interface: convergence of neural regeneration and neural prostheses for restoration of function. J Rehabil Res Dev 38:633-9
Liu, S; Qu, Y; Stewart, T J et al. (2000) Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 97:6126-31

Showing the most recent 10 out of 11 publications